Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

KBA3D

K-Number: K223841 · 2023-05-30

ApplicantS.M.A.I.O
Decision Date2023-05-30
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

KBA3D is the device name listed in this FDA 510(k) record. The listed applicant is S.M.A.I.O. It received FDA 510(k) clearance on 2023-05-30 under 510(k) number K223841. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the KBA3D?

KBA3D is a medical device that received FDA 510(k) clearance on 2023-05-30. The listed applicant is S.M.A.I.O. The 510(k) number is K223841.

When did KBA3D receive FDA 510(k) clearance?

KBA3D received FDA 510(k) clearance on 2023-05-30, under 510(k) number K223841.

Who is the listed applicant for KBA3D?

The FDA 510(k) record lists S.M.A.I.O as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for KBA3D?

The FDA product code for KBA3D is LLZ.

Other records listing S.M.A.I.O as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 11 devices →

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.